Table 1.
Variables used in GLMM Models.
| Predictors | Court
Offers MAT |
Number
of Court Participants Receiving MAT |
|---|---|---|
| Level | Level | |
| Medicaid expansion state (Yes = 1; 0 = No) | State (3) | State (3) |
| State mandates the types of treatment programs and services used (1 = Yes; 0 = No) | State (3) | n/a |
| State mandates MAT training for court staff (1 = Yes; 0 = No) | n/a | State (3) |
| State mandates eligibility criteria to admit participants to PSC (1 = Yes; 0 = No) | n/a | State (3) |
| Percent of population that is opioid dependent | County (2) | County (2) |
| Drug overdose mortality rate (deaths/100k pop) | County (2) | County (2) |
| Buprenorphine patient capacity (patient limit/1k pop) | County (2) | n/a |
| Methadone providers (providers/100k pop.) | County (2) | n/a |
| Naltrexone providers (providers/100k pop.) | County (2) | n/a |
| PSC type (substance use = 1; other = 0) | Court (1) | Court (1) |
| There is a perception in the court that MAT is “just substituting one drug for another”a | Court (1) | n/a |
| “Most participants in our court are not interested in MAT services”a | Court (1) | n/a |
| PSC participants are given a choice over which MAT to receiveb | n/a | Court (1) |